Skip to search formSkip to main contentSkip to account menu

CGP 28392

Known as: CGP-28392, Furo(3,4-b)pyridine-3-carboxylic acid, 4-(2-(difluoromethoxy)phenyl)-1,4,5,7-tetrahydro-2-methyl-5-oxo-, ethyl ester 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
Background: The goal of this study was to investigate the modulation of the contraction-relaxation effects in isolated human… 
2009
1990
1990
The effects of nimodipine (voltage-dependent calcium channel blocker), CGP 28392 and BAY K 8644 (novel dihydropyridine… 
1990
1990
The effects of Ca2+ antagonists (nicardipine, felodipine, nitrenedipine, isradipine, niphedipine, darodipine and riodipine) and… 
1987
1987
Isoproterenol (ISO) augments the slow inward Ca current in cardiac muscle cells. We examined the role of intracellular Na (Nai… 
1986
1986
Summary: The effect of BAY K 8644 was compared to that of CGP 28392 in isolated rat thoracic aorta. In low concentration both… 
1985
1985
Recently, the novel dihydropyridine derivates YC-170, CGP 28392, and BAY K 8644 have been reported to act in the opposite way to… 
1985
1985
CGP 28392 is a recently described dihydropyridine derivative with positive inotropic properties. To study the mechanism of action… 
1985
1985
The rate of insulin secretion from isolated rat islets of Langerhans was affected by a number of dihydropyridine derivatives… 
1985
1985
The organic calcium-agonist CGP 28392 augmented insulin release evoked by D-glucose in rat pancreatic islets incubated in the…